Clinical trial
Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain…
NCT00498303 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00498303 |
|---|---|
| Title | Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008 |
| Official title | A Phase III, Multicenter, Uncontrolled, Open-Label Study to Evaluate Safety and Immunogenicity of Preservative Free, Inactivated Split Influenza Vaccine, Using the Strain Composition 2007/2008 When Administered to Adult and Elderly Subjects |
| Lead sponsor | Novartis, Industry |
| Collaborators | Novartis Vaccines Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seasonal Influenza, Vaccine |
| Intervention type | Biological |
| Interventions | trivalent split influenza vaccine |
| Enrollment | 120 |
| Start date | Jun 1, 2007 |
| First posted | Jul 10, 2007 |
| Last update posted | Apr 22, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: